3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide
C80H68Ir4N12-8 — CID 159417650
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide
3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide (PubChem CID 159417650) has the molecular formula C80H68Ir4N12-8 and a molecular weight of 1966.38 g/mol. Its IUPAC name is 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide.
Molecular Properties
| Compound Name | 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide |
|---|---|
| PubChem CID | 159417650 |
| Molecular Formula | C80H68Ir4N12-8 |
| Molecular Weight | 1966.38 g/mol |
| Exact Mass | 1968.43 |
| IUPAC Name | 3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide |
| SMILES | Cc1ccccc1N1[CH-]N(c2[c-]cc(C(C)(C)C)cc2)c2ncccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2ccccc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2cccnc21.Cc1ccccc1N1[CH-]N(c2[c-]cccc2)c2nccnc21.[Ir].[Ir].[Ir].[Ir] |
| InChI | InChI=1S/C23H23N3.C20H16N2.C19H15N3.C18H14N4.4Ir/c1-17-8-5-6-9-20(17)26-16-25(22-21(26)10-7-15-24-22)19-13-11-18(12-14-19)23(2,3)4;1-16-9-5-6-12-18(16)22-15-21(17-10-3-2-4-11-17)19-13-7-8-14-20(19)22;1-15-8-5-6-11-17(15)22-14-21(16-9-3-2-4-10-16)18-12-7-13-20-19(18)22;1-14-7-5-6-10-16(14)22-13-21(15-8-3-2-4-9-15)17-18(22)20-12-11-19-17;;;;/h5-13,15-16H,1-4H3;2-10,12-15H,1H3;2-9,11-14H,1H3;2-8,10-13H,1H3;;;;/q4*-2;;;; |
| InChIKey | VGRRMKUQFSNOQJ-UHFFFAOYSA-N |
| XLogP | 19.68 |
| TPSA | 77.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 96 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1966.38 |
| LogP ≤ 5 | 19.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159417650 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.